News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
54,660 Results
Type
Article (4804)
Company Profile (13)
Press Release (49843)
Section
Business (17024)
Career Advice (257)
Deals (2639)
Drug Delivery (8)
Drug Development (2875)
Employer Resources (23)
FDA (1103)
Job Trends (1680)
News (24000)
Policy (2108)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (558)
Allergies (3)
Alliances (5756)
ALS (1)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (8)
Approvals (1100)
Artificial intelligence (53)
Autoimmune disease (4)
Automation (8)
Bankruptcy (24)
Best Places to Work (1174)
BIOSECURE Act (1)
Biosimilars (8)
Biotechnology (5)
Bladder cancer (2)
Brain cancer (3)
Breast cancer (14)
Cancer (163)
Cardiovascular disease (12)
Career advice (225)
Career pathing (11)
CAR-T (7)
Cell therapy (30)
Cervical cancer (6)
Clinical research (1858)
Collaboration (101)
Compensation (1)
COVID-19 (428)
CRISPR (8)
C-suite (17)
Cystic fibrosis (7)
Data (114)
Depression (2)
Diabetes (8)
Diagnostics (1727)
Digital health (2)
Diversity, equity & inclusion (3)
Drug discovery (17)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (2)
Earnings (4401)
Editorial (1)
Employer branding (2)
Employer resources (21)
Events (5755)
Executive appointments (64)
FDA (1168)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (95)
Gene editing (12)
Generative AI (3)
Gene therapy (20)
GLP-1 (47)
Government (465)
Grass and pollen (1)
Guidances (4)
Healthcare (1525)
Huntington's disease (1)
Immunology and inflammation (7)
Infectious disease (446)
Inflammatory bowel disease (11)
Influenza (16)
Intellectual property (3)
Interviews (34)
IPO (898)
IRA (2)
Job creations (513)
Job search strategy (198)
Labor market (9)
Layoffs (37)
Leadership (9)
Legal (348)
Liver cancer (2)
Lung cancer (17)
Lymphoma (10)
Machine learning (3)
Management (5)
Manufacturing (44)
Medical device (981)
Medtech (981)
Mergers & acquisitions (1793)
Metabolic disorders (25)
Multiple sclerosis (3)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (153)
NextGen: Class of 2025 (713)
Non-profit (544)
Northern California (198)
Now hiring (12)
Obesity (18)
Opinion (39)
Ovarian cancer (5)
Pain (7)
Pancreatic cancer (5)
Parkinson's disease (14)
Partnered (6)
Patents (5)
Patient recruitment (3)
Peanut (3)
People (4723)
Pharmaceutical (2)
Phase I (681)
Phase II (830)
Phase III (659)
Pipeline (111)
Policy (6)
Postmarket research (91)
Preclinical (491)
Press Release (18)
Prostate cancer (11)
Psychedelics (4)
Radiopharmaceuticals (12)
Rare diseases (14)
Real estate (1427)
Recruiting (13)
Regulatory (1430)
Reports (11)
Research institute (521)
Resumes & cover letters (30)
Rett syndrome (1)
RNA editing (1)
RSV (3)
Schizophrenia (3)
Series A (17)
Series B (8)
Service/supplier (2)
Sickle cell disease (1)
Southern California (146)
Special edition (2)
Spinal muscular atrophy (5)
Sponsored (6)
Startups (486)
Supply chain (8)
Tariffs (3)
United States (1761)
Vaccines (27)
Venture capitalists (6)
Weight loss (9)
Women's health (2)
Worklife (4)
Date
Today (19)
Last 7 days (63)
Last 30 days (223)
Last 365 days (2454)
2025 (756)
2024 (2724)
2023 (3286)
2022 (4747)
2021 (4998)
2020 (5651)
2019 (4215)
2018 (3015)
2017 (2943)
2016 (3146)
2015 (3166)
2014 (2184)
2013 (1946)
2012 (2079)
2011 (2192)
2010 (1620)
Location
Africa (107)
Alabama (6)
Alaska (1)
Arizona (22)
Arkansas (1)
Asia (3058)
Australia (410)
California (439)
Canada (148)
China (31)
Colorado (19)
Connecticut (39)
Delaware (8)
Europe (6086)
Florida (36)
Georgia (20)
Idaho (4)
Illinois (33)
India (6)
Indiana (31)
Iowa (3)
Japan (8)
Kansas (5)
Kentucky (1)
Louisiana (1)
Maine (6)
Maryland (51)
Massachusetts (329)
Michigan (58)
Minnesota (30)
Missouri (13)
Montana (3)
Nebraska (5)
Nevada (6)
New Hampshire (6)
New Jersey (95)
New Mexico (11)
New York (133)
North Carolina (85)
North Dakota (2)
Northern California (198)
Ohio (35)
Oklahoma (3)
Oregon (6)
Pennsylvania (105)
Rhode Island (2)
South America (190)
South Carolina (4)
Southern California (146)
Tennessee (19)
Texas (68)
Utah (31)
Virginia (14)
Washington D.C. (1)
Washington State (45)
West Virginia (1)
Wisconsin (8)
54,660 Results for "bioage labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
BioAge Drops Lead Obesity Asset Months After IPO
It’s been a rocky few months for BioAge Labs, which shuttered a Phase II trial of its lead candidate azelaprag Tuesday after the molecule caused liver-based side effects.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
BioAge Labs to Participate in TD Cowen’s 45th Annual Health Care Conference
February 21, 2025
·
1 min read
Press Releases
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
March 20, 2025
·
11 min read
Press Releases
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
January 29, 2025
·
5 min read
Press Releases
BioAge Labs to Present at Upcoming Investor Conferences
November 22, 2024
·
1 min read
Press Releases
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic
December 6, 2024
·
1 min read
Business
BioAge Labs Announces Inaugural Scientific Advisory Board to Support Advancement of Novel Therapeutics Targeting Metabolic Aging
BioAge Labs, Inc. today announced the formation of its Scientific Advisory Board (SAB).
May 15, 2024
·
5 min read
Press Releases
BioAge Labs to Present at Jefferies London Healthcare Conference
October 24, 2024
·
1 min read
Press Releases
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
November 4, 2024
·
3 min read
Drug Development
BioAge Labs Presents Preclinical Data for Apelin Receptor Agonist Azelaprag for Obesity Demonstrating Significant Improvements in Weight Loss and Body Composition When Combined with Incretin Drugs
BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutic candidates for metabolic diseases, such as obesity, by targeting the biology of aging, today announced preclinical data for its lead product candidate azelaprag, an orally available small molecule agonist of the apelin receptor APJ, in combination with incretin agonists for the treatment of obesity.
June 21, 2024
·
4 min read
1 of 5,466
Next
